-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
Co-Founder, Fate Therapeutics
-
Co-Founder and CEO, 23andMe
-
President of Stratos Product Development
-
Chief Revenue Officer, RealGames North America
-
Meet All the Xconomists ›
-
Chairman, Entrepreneurship Ventures, Inc.
-
Prof., Molecular Biology and Chemistry, Scripps Research Institute
-
Professor, Laboratory of Genetics, Salk Institute
-
CEO and Founder, Intellectual Ventures
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Heavyweight Hydrogen Takes $37 Million Prize for Concert Pharmaceuticals
|
Erik Mellgren |
05/01/08 |
Boston
|
|
GSK Takes Sirtris and Taps Alnylam Venture, FDA Deals Genzyme Drug a Blow, Resolvyx Finances Fish-Oil Drugs, & More Life Sciences News
|
Rebecca Zacks |
04/23/08 |
Boston
|
|
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million
|
Erik Mellgren |
04/17/08 |
Boston
|
|
In Latest Local Venture Philanthropy Deal, Cystic Fibrosis Foundation Pledges up to $37.7 More to Epix
|
Rebecca Zacks |
04/07/08 |
Boston
|
|
Mello RNAi Firm RXi Pharmaceuticals Has Wild Ride on First Day of Trading
|
Rebecca Zacks |
03/12/08 |
Boston
|
|
Thermo Fisher Simplifies RNAi Delivery
|
Wade Roush |
03/10/08 |
Boston
|
|
Biogen’s Busy Week, Alnylam’s Big Announcement, Targanta’s and Momenta’s Growing Executive Ranks, & More Life Sciences News
|
Rebecca Zacks |
03/05/08 |
Boston
|
|
Alnylam Touts Early Evidence of RNAi Drug Efficacy
|
Wade Roush |
02/29/08 |
Boston
|
|
Alnylam’s John Maraganore Anticipates More RNAi Deals and Startups in “Unparalleled” Environment for Biotech
|
Malorye Allison |
01/07/08 |
Boston
|
|
Of Red Wine, Robotics, and What Folks Would Do As Governor—Xconomy’s Forum Sparks Debate on the Future of Innovation in New England
|
Rebecca Zacks |
12/06/07 |
Boston
|
|
Dicerna Officially Founded
|
Malorye Allison |
11/14/07 |
Boston
|
|
Will it Rain RNAi Companies? Dicerna Co-Founder John Rossi Says New IP Opens Avenues
|
Malorye Allison |
11/06/07 |
Boston
|
|
RNAi Firms Find a New Rival (and Partner) in an Old Technology
|
Malorye Allison |
10/04/07 |
Boston
|
|
Alnylam and Merck Go Their Separate Ways, TransMedics Files to Go Public, ZipCar Reservation System Ready to Go Anywhere, and More
|
Rebecca Zacks |
09/24/07 |
Boston
|
|
Mass Biotech Council’s Image Troubles, Boston Scientific’s Mixed Bag, Another Big IPO in the Offing, and More
|
Rebecca Zacks |
09/10/07 |
Boston
|
|
Follow-Up: Alnylam’s Biodefense Contract the Program’s Largest
|
Rebecca Zacks |
08/10/07 |
Boston
|
|
More Government Dollars for Alnylam Biodefense Initiative
|
Rebecca Zacks |
08/09/07 |
Boston
|
|
Page 2 of
2 |
« previous page |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.